New York, NY, November 17, 2021 – Strive Medical (“Strive” or the “Company”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Summit Xpress Medical Supply (“Summit Xpress”), a leading regional distributor of urological supplies to patients in the home setting. Terms of the transaction were not disclosed. Anthony You, owner and […]
New York, NY, October 14, 2021 – NMS Capital (“NMS”) portfolio company Flourish Research (“Flourish”) announced today that it has partnered with company management in the recapitalization of Excel Medical Clinical Trials, LLC (“Excel”). Excel is a leading clinical research site focused on Cardiology and related conditions serving leading pharmaceutical companies and CROs founded in […]
New York, NY, October 5, 2021 – U.S. Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Appalachian Foot & Ankle Associates (the “Practice”), based in North Carolina. Appalachian Foot & Ankle Associates has served the podiatry needs of Western North Carolina since 1997. Founded […]
We all have someone around us who is in a state related to brain development. Autism sounds not as dangerous as cancer, but this condition impacts how a person observes and socializes with others, and having this disorder causing problems in social interaction and communication. As a result, some people with ASD may need special […]
New York, NY, August 18, 2021 – NMS Capital (“NMS”) is pleased to announce today that Kevin Connelly has joined the firm as a Vice President within NMS’ Portfolio Optimization Group (“POG”) increasing the existing team resources. His experience leading corporate strategy and operational improvement efforts will enhance the firm’s strategy of working closely with […]
New York, NY, August 12, 2021 – NMS Capital (“NMS”) announced today that it has formed Flourish Research (“Flourish”), which will aim to become a leading, nationwide network of clinical research sites with therapeutic area and clinical trial phase diversity. For its initial investment in Flourish Research, NMS has completed the recapitalization of Clinical Trials […]
New York, NY, August 3, 2021 – U.S. Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired M&L Podiatry, based in North Carolina. M&L Podiatry has a longstanding family history that makes it the trusted choice among citizens of the Waxhaw, Lincolnton and Matthews, NC […]
New York, NY, July 7, 2021 – NMS Capital (“NMS”) announced today that it has partnered with Company management in the recapitalization of DirectMed Parts & Service, LLC (“DirectMed” or the “Company”). Terms of the transaction were not disclosed. Headquartered in San Diego, CA, DirectMed is the largest independent source for service and supply of […]
New York, NY, July 7, 2021 – U.S. Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Family Foot and Ankle Center (“FFAC”), based in Northern Virginia. Dr. Richard Mendelsohn founded FFAC in 1987, and has since expanded to four locations in Ashburn, Fairfax, McLean, […]
New York, NY, July 7, 2021 – NMS Capital (“NMS”), announced today a new executive partnership with Chuck Casalinova to pursue platform investments in the Environmental Services industry. Mr. Casalinova has joined NMS’s Operating Executive Council (“OEC”), which is comprised of experienced industry leaders and operating executives. NMS OEC members work alongside NMS and portfolio […]
NMS Capital is a private investment firm specializing in strategic equity investments of leading middle market companies with an emphasis on sustainable growth trends in both the business services and healthcare services industries.
We partner with founders and management teams to help accelerate growth and build a wide range of leading companies across the business services and healthcare services sectors.
